CATHERINE THOMAS: Open Payments
NPI 1811750003 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $243 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $142 |
| GENZYME CORPORATION | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $76 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
Products named: TEPEZZA, DUPIXENT, Livdelzi, Asparlas.
Industry payments across TX — which companies pay providers there.
